Paul T. Caldwell - Concepedia

Author

Paul T. Caldwell

Research Triangle Park Foundation

Also Known As

P Caldwell, Paul Caldwell, Paul T. Caldwell

Publications

494

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation Toronto General Hospital University of Rhode Island GlaxoSmithKline (United States)

About

Paul T. Caldwell is an author at Research Triangle Park Foundation specializing in pharmacology, medicine, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	156
2	Pharmacology	5	5	156
3	Biochemistry	2	2	102
4	Metabolism	2	2	102
5	Pulmonary Medicine	1	1	12

Paul T. Caldwell

Publications

412

Citations

H-Index

Page 1

	Year	Citations
Atovaquone Suspension Compared with Aerosolized Pentamidine for Prevention of<i>Pneumocystis carinii</i>Pneumonia in Human Immunodeficiency Virus–Infected Subjects Intolerant of Trimethoprim or Sulfonamides Charles K. Chan, Eric‐Albert Lefebvre, G. E. Morey, The Journal of Infectious Diseases	1999	97
Oral Atovaquone Compared with Intravenous Pentamidine for <i>Pneumocystis carinii</i> Pneumonia in Patients with AIDS Michael N. Dohn, Winkler G. Weinberg, Ramón A. Torres, Annals of Internal Medicine	1994	96
Mechanism of warfarin resistance. Warfarin and the metabolism of vitamin K1 Robert G. Bell, Paul T. Caldwell Biochemistry Vitamin K AntagonistsTherapeutic Drug MonitoringWarfarin ResistanceBiochemistryMedicine	1973	75
Atovaquone suspension for treatment of Pneumocystis carinii pneumonia in HIV-infected patients D Rosenberg, William McCarthy, Joseph Slavinsky, AIDS	2001	34
Warfarin and metabolism of vitamin K1 Paul T. Caldwell, Peter Ren, Robert G. Bell Biochemical Pharmacology Vitamin K AntagonistsEnergy MetabolismBiochemistryMedicineMetabolomic Profiling	1974	27
Coumarins and the vitamin K-K epoxide cycle. Lack of resistance to coumatetralyl in warfarin-resistant rats Robert G. Bell, Paul T. Caldwell, Eric E.T. Holm Biochemical Pharmacology Molecular PharmacologyPharmacologyMedicineWarfarin-resistant RatsOxidative Stress	1976	23
Long-Term Tolerability and Safety of Lamotrigine Extended-Release: Pooled Analysis of Three Clinical Trials Victor Biton, Bassel F. Shneker, Dean K. Naritoku, Clinical Drug Investigation Long-term TolerabilityPharmacologyPharmacotherapyMedicineThree Clinical Trials	2013	19
Open-Label Phase II Trial of Amprenavir, Abacavir, and Fixed-Dose Zidovudine/Lamivudine in Newly and Chronically HIV-1–Infected Patients Rhonda G. Kost, Arlene Hurley, Linqi Zhang, JAIDS Journal of Acquired Immune Deficiency Syndromes	2001	15
Relative influences of adjunctive topiramate and adjunctive lamotrigine on scanning and the effective field of view Kenneth C. Mills, Joseph F. Drazkowski, Anne E. Hammer, Epilepsy Research OphthalmologyEye TrackingAdjunctive TopiramateVision ResearchRelative Influences	2007	14
Open-label efficacy and safety trial of 42 days of 566C80 for Pneumocystis carinii pneumonia in AIDS patients. Dohn Mn, Frame Pt, Baughman Rp, PubMed PharmacotherapyAntimicrobial ChemotherapyPneumocystis Carinii PneumoniaAntiviral DrugDrug Resistance	1992	12

Page 1